No Data
No Data
Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
Express News | Zentalis Pharmaceuticals Inc - Topline Data From Denali Part 2 Expected by Year End 2026
Express News | Zentalis Pharmaceuticals Announces First Patient Dosed in Denali Part 2 Clinical Trial of Azenosertib in Patients With Cyclin E1+ Proc
Express News | Zentalis Pharmaceuticals To Present Poster At 2025 ASCO Annual Meeting
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
Express News | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)